Glaxosmithkline Company Profile

Aggregated data from the web about Glaxosmithkline

Company Name	Glaxosmithkline
Website	https://us.gsk.com
Snippet	WebPress releases. 13 July 2023 GSK is first to ship influenza vaccine doses for the 2023-24 flu season in US. 27 June 2023 GSK receives US FDA Fast Track designation for …
ISIN	GB0009252882
Type	Public limited company
Founded	2000
Revenue	GB£33.754 billion[1] (2019)
Website	www.gsk.com
Industry	PharmaceuticalBiotechnologyConsumer goods
Products	Pharmaceuticals, vaccines, oral healthcare, nutritional products, over-the-counter medicines
Traded as	LSE: GSKNYSE: GSKFTSE 100 Component
Key people	Jonathan Symonds (chairperson), Emma Walmsley (CEO)
Net income	GB£4.645 billion[1] (2019)
Area served	Worldwide
Headquarters	Brentford, England, UK
Predecessors	Glaxo Wellcome, Beecham Group, Smith, Kline & French
Subsidiaries	Stiefel Laboratories, Tesaro, ViiV Healthcare (76.5%)
Operating income	GB£6.961 billion[1] (2019)
Number of employees	99,437[1] (2019)

Glaxosmithkline is part of the United Kingdom company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.